Lexology March 27, 2025
After months of back and forth and uncertainty related to efforts under the new Trump Administration to reduce the size of the federal government, U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced plans today to significantly decrease the size of HHS, which includes the U.S. Food and Drug Administration (FDA). The planned changes include reducing the HHS workforce by 10,000 full-time employees across various divisions, including an estimated 3,500 from the FDA. These reductions come in addition to the estimated 10,000 employees who have willingly left HHS since the Trump Administration took office. The Administration maintains that essential health services will not be affected.
The stated goals of the plan are to reorganize HHS...